Inicio › Enfermedad de obstrucción pulmonar crónica › Texas › Houston
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Houston, TX
18 estudios para Enfermedad de obstrucción pulmonar crónica buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
ReclutandoFase 3
- GSK Investigational Site, Humble · A 17 mi de distancia
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
ReclutandoFase 2
- Baylor College of Medicine Medical Center, Houston
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2
- Research Site, Houston
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- Se Houston- Site Number : 8400120, Houston
- Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2/3
- Greater Heights & Memorial Pulmonary and Sleep, Houston
- Houston Pulmonary Sleep and Allergy Associates, Houston
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Reclutando
- Houston Methodist/Primary Critical Care, Houston
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- Trio Clinical Trials- Site Number : 8400106, Houston
- HDH Research, Inc.- Site Number : 8400104, Houston
- Baylor College of Medicine- Site Number : 8400076, Houston
- y 2 más
STRIVE Post-Market Registry Study
ReclutandoEstudio observacional
- University of Texas Health Science Center at Houston, Houston
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
ReclutandoEstudio observacional
- The Respire Institute, Houston
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
ReclutandoFase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
ReclutandoFase 3
- GSK Investigational Site, Houston
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ReclutandoFase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
ReclutandoFase 2
- Baylor College of Medicine, Houston
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ReclutandoFase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · A 17 mi de distancia
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
ReclutandoEstudio observacional
- Horizon Clinical Research Group, Houston
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Reclutando
- Respire Research Institute, Houston
Más información sobre Enfermedad de obstrucción pulmonar crónica en MedlinePlus
Ensayos de Enfermedad de obstrucción pulmonar crónica en otras ciudades
- Philadelphia, PA26 estudios
- Miami, FL20 estudios
- Birmingham, AL17 estudios
- Baltimore, MD16 estudios
- Boston, MA15 estudios
- Orlando, FL15 estudios
- Chicago, IL15 estudios
- Dallas, TX13 estudios
- New York City, NY12 estudios
- Pittsburgh, PA11 estudios
- Winston-Salem, NC11 estudios
- Hialeah, FL10 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas143 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)124 estudios
- Cáncer del colon y del recto101 estudios
- Cáncer metastásico100 estudios
- Cáncer de ovario90 estudios
- Leucemia mielógena aguda88 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata73 estudios
- Cáncer de endometrio69 estudios
- Melanoma61 estudios
- Cáncer de páncreas59 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.